Candel Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Candel Therapeutics Operating Expenses Growth & History (CADL)
Candel Therapeutics's operating expenses was $48.3M for fiscal 2025.
View full Candel Therapeutics company overviewCandel Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $48.3M | $14.9M | +44.63% |
| 2024 | 2024-12-31 | $33.4M | −$5.0M | −13.08% |
| 2023 | 2023-12-31 | $38.4M | $3.5M | +10.17% |
| 2022 | 2022-12-31 | $34.8M | $9.0M | +34.80% |
| 2021 | 2021-12-31 | $25.9M | $11.9M | +85.51% |
| 2020 | 2020-12-31 | $13.9M | — | — |
Candel Therapeutics quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.7M | $15.6M | +139.29% |
| Q1 2026 | 2026-03-31 | $16.3M | $8.2M | +100.30% |
| Q4 2025 | 2025-12-31 | $15.8M | $7.6M | +93.49% |
| Q3 2025 | 2025-09-30 | $13.2M | $4.5M | +50.82% |
| Q2 2025 | 2025-06-30 | $11.2M | $2.6M | +30.40% |
| Q1 2025 | 2025-03-31 | $8.1M | $228,000 | +2.89% |
| Q4 2024 | 2024-12-31 | $8.1M | −$2.2M | −21.10% |
| Q3 2024 | 2024-09-30 | $8.8M | −$104,000 | −1.17% |
| Q2 2024 | 2024-06-30 | $8.6M | −$1.0M | −10.52% |
| Q1 2024 | 2024-03-31 | $7.9M | −$1.7M | −17.97% |
| Q4 2023 | 2023-12-31 | $10.3M | $2.2M | +26.85% |
| Q3 2023 | 2023-09-30 | $8.9M | −$51,000 | −0.57% |
| Q2 2023 | 2023-06-30 | $9.6M | $795,000 | +9.05% |
| Q1 2023 | 2023-03-31 | $9.6M | $616,000 | +6.83% |
| Q4 2022 | 2022-12-31 | $8.1M | $363,000 | +4.67% |
| Q3 2022 | 2022-09-30 | $8.9M | $852,000 | +10.57% |
| Q2 2022 | 2022-06-30 | $8.8M | $3.5M | +64.74% |
| Q1 2022 | 2022-03-31 | $9.0M | $4.3M | +92.34% |
| Q4 2021 | 2021-12-31 | $7.8M | — | — |
| Q3 2021 | 2021-09-30 | $8.1M | $5.3M | +189.93% |
| Q2 2021 | 2021-06-30 | $5.3M | $2.7M | +101.21% |
| Q1 2021 | 2021-03-31 | $4.7M | — | — |
| Q3 2020 | 2020-09-30 | $2.8M | — | — |
| Q2 2020 | 2020-06-30 | $2.6M | — | — |
Candel Therapeutics operating expenses trends
Over the last five fiscal years, Candel Therapeutics's operating expenses increased from $13.9M to $48.3M, a change of $34.3M. The latest reported quarter, Q2 2026, shows $26.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Candel Therapeutics source filings ↗